363 related articles for article (PubMed ID: 15946680)
1. Functional cartography of the ectodomain of the type I interferon receptor subunit ifnar1.
Lamken P; Gavutis M; Peters I; Van der Heyden J; Uzé G; Piehler J
J Mol Biol; 2005 Jul; 350(3):476-88. PubMed ID: 15946680
[TBL] [Abstract][Full Text] [Related]
2. Identification of residues of the IFNAR1 chain of the type I human interferon receptor critical for ligand binding and biological activity.
Cajean-Feroldi C; Nosal F; Nardeux PC; Gallet X; Guymarho J; Baychelier F; Sempé P; Tovey MG; Escary JL; Eid P
Biochemistry; 2004 Oct; 43(39):12498-512. PubMed ID: 15449939
[TBL] [Abstract][Full Text] [Related]
3. Ligand binding induces a conformational change in ifnar1 that is propagated to its membrane-proximal domain.
Strunk JJ; Gregor I; Becker Y; Li Z; Gavutis M; Jaks E; Lamken P; Walz T; Enderlein J; Piehler J
J Mol Biol; 2008 Mar; 377(3):725-39. PubMed ID: 18294654
[TBL] [Abstract][Full Text] [Related]
4. Ligand-induced assembling of the type I interferon receptor on supported lipid bilayers.
Lamken P; Lata S; Gavutis M; Piehler J
J Mol Biol; 2004 Jul; 341(1):303-18. PubMed ID: 15312780
[TBL] [Abstract][Full Text] [Related]
5. Characterization of a soluble ternary complex formed between human interferon-beta-1a and its receptor chains.
Arduini RM; Strauch KL; Runkel LA; Carlson MM; Hronowski X; Foley SF; Young CN; Cheng W; Hochman PS; Baker DP
Protein Sci; 1999 Sep; 8(9):1867-77. PubMed ID: 10493588
[TBL] [Abstract][Full Text] [Related]
6. Mutational and structural analysis of the binding interface between type I interferons and their receptor Ifnar2.
Piehler J; Schreiber G
J Mol Biol; 1999 Nov; 294(1):223-37. PubMed ID: 10556041
[TBL] [Abstract][Full Text] [Related]
7. The IFNAR1 subunit of the type I IFN receptor complex contains a functional nuclear localization sequence.
Subramaniam PS; Johnson HM
FEBS Lett; 2004 Dec; 578(3):207-10. PubMed ID: 15589821
[TBL] [Abstract][Full Text] [Related]
8. Shared receptor components but distinct complexes for alpha and beta interferons.
Lewerenz M; Mogensen KE; Uzé G
J Mol Biol; 1998 Sep; 282(3):585-99. PubMed ID: 9737924
[TBL] [Abstract][Full Text] [Related]
9. Evidence for glycosphingolipid modification of the type 1 IFN receptor.
Ghislain J; Lingwood CA; Fish EN
J Immunol; 1994 Oct; 153(8):3655-63. PubMed ID: 7930586
[TBL] [Abstract][Full Text] [Related]
10. NMR backbone dynamics of the human type I interferon binding subunit, a representative cytokine receptor.
Chill JH; Quadt SR; Anglister J
Biochemistry; 2004 Aug; 43(31):10127-37. PubMed ID: 15287740
[TBL] [Abstract][Full Text] [Related]
11. Functional significance of globotriaosyl ceramide in interferon-alpha(2)/type 1 interferon receptor-mediated antiviral activity.
Khine AA; Lingwood CA
J Cell Physiol; 2000 Jan; 182(1):97-108. PubMed ID: 10567921
[TBL] [Abstract][Full Text] [Related]
12. Structure-function study of the extracellular domain of the human IFN-alpha receptor (hIFNAR1) using blocking monoclonal antibodies: the role of domains 1 and 2.
Lu J; Chuntharapai A; Beck J; Bass S; Ow A; De Vos AM; Gibbs V; Kim KJ
J Immunol; 1998 Feb; 160(4):1782-8. PubMed ID: 9469437
[TBL] [Abstract][Full Text] [Related]
13. Comparable potency of IFNalpha2 and IFNbeta on immediate JAK/STAT activation but differential down-regulation of IFNAR2.
Marijanovic Z; Ragimbeau J; van der Heyden J; Uzé G; Pellegrini S
Biochem J; 2007 Oct; 407(1):141-51. PubMed ID: 17627610
[TBL] [Abstract][Full Text] [Related]
14. Homology model of human interferon-alpha 8 and its receptor complex.
Seto MH; Harkins RN; Adler M; Whitlow M; Church WB; Croze E
Protein Sci; 1995 Apr; 4(4):655-70. PubMed ID: 7613464
[TBL] [Abstract][Full Text] [Related]
15. The antiviral action of interferon is potentiated by removal of the conserved IRTAM domain of the IFNAR1 chain of the interferon alpha/beta receptor: effects on JAK-STAT activation and receptor down-regulation.
Basu L; Yang CH; Murti A; Garcia JV; Croze E; Constantinescu SN; Mullersman JE; Pfeffer LM
Virology; 1998 Mar; 242(1):14-21. PubMed ID: 9501047
[TBL] [Abstract][Full Text] [Related]
16. Differential receptor subunit affinities of type I interferons govern differential signal activation.
Jaks E; Gavutis M; Uzé G; Martal J; Piehler J
J Mol Biol; 2007 Feb; 366(2):525-39. PubMed ID: 17174979
[TBL] [Abstract][Full Text] [Related]
17. Formation of a uniquely stable type I interferon receptor complex by interferon beta is dependent upon particular interactions between interferon beta and its receptor and independent of tyrosine phosphorylation.
Russell-Harde D; Wagner TC; Perez HD; Croze E
Biochem Biophys Res Commun; 1999 Feb; 255(2):539-44. PubMed ID: 10049744
[TBL] [Abstract][Full Text] [Related]
18. Determination of residues involved in ligand binding and signal transmission in the human IFN-alpha receptor 2.
Chuntharapai A; Gibbs V; Lu J; Ow A; Marsters S; Ashkenazi A; De Vos A; Jin Kim K
J Immunol; 1999 Jul; 163(2):766-73. PubMed ID: 10395669
[TBL] [Abstract][Full Text] [Related]
19. Characterization of the alpha subunit of the IFN-alpha receptor. Evidence of N- and O-linked glycosylation and association with other surface proteins.
Platanias LC; Pfeffer LM; Cruciani R; Colamonici OR
J Immunol; 1993 Apr; 150(8 Pt 1):3382-8. PubMed ID: 8468477
[TBL] [Abstract][Full Text] [Related]
20. Mutational analysis of the IFNAR1 binding site on IFNalpha2 reveals the architecture of a weak ligand-receptor binding-site.
Roisman LC; Jaitin DA; Baker DP; Schreiber G
J Mol Biol; 2005 Oct; 353(2):271-81. PubMed ID: 16171819
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]